Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute

Xavier Bosch1, Pierre Théroux

  • 1Institut de Malalties Cardiovasculars, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

American Heart Journal
|August 10, 2005
PubMed

Insights

Left ventricular ejection fraction (EF) significantly improves risk stratification for patients with non-ST-segment elevation acute coronary syndrome (ACS). Adding EF to the Thrombolysis in Myocardial Infarction (TIMI) risk score enhances prediction of in-hospital mortality.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Cardiovascular Research

Background:

  • Accurate risk stratification is crucial for optimal treatment of non-ST-segment elevation acute coronary syndrome (ACS).
  • Current risk stratification models may not fully capture prognostic information.
  • The role of left ventricular ejection fraction (EF) in refining ACS risk assessment requires further investigation.

Purpose of the Study:

  • To evaluate the incremental prognostic value of routine left ventricular ejection fraction (EF) determination.
  • To assess if EF improves risk stratification beyond established predictors in ACS patients.
  • To determine the optimal EF cutoff for predicting in-hospital mortality.

Main Methods:

  • A registry study of 1104 consecutive ACS patients with prospectively determined EF.
  • Multiple regression models incorporating clinical, electrocardiographic, and biomarker stratifiers.
  • EF values were added to established models to assess predictive improvement.

Main Results:

  • Age, ST-segment shifts, cardiac markers, and TIMI risk score were significant mortality predictors (P < .0001).
  • Inclusion of EF improved mortality prediction (C statistic 0.73 vs 0.67).
  • A lower EF (<48%) was associated with significantly higher mortality rates across all TIMI risk strata.

Conclusions:

  • The Thrombolysis in Myocardial Infarction (TIMI) risk score effectively predicts in-hospital mortality in ACS.
  • Routine assessment of left ventricular ejection fraction (EF) provides significant additional prognostic information.
  • EF measurement enhances the risk stratification of ACS patients, guiding more judicious treatment decisions.
Abstract